|
neutrophil dispersal
|
GO_0140635 |
[The movement of a neutrophil away from the site of wound or infection following its initial migration to the site.] |
|
optical nerve axon regeneration
|
GO_0101027 |
[The regrowth of axons of the optical nerve following their loss or damage.] |
|
small conductance calcium-activated potassium channel inhibitor activity
|
GO_0140629 |
[Binds to and stops, prevents, or reduces the activity of a small conductance calcium-activated potassium channel.] |
|
outward rectifier potassium channel inhibitor activity
|
GO_0140628 |
[Binds to and stops, prevents, or reduces the activity of an outwardly rectifying potassium channel.] |
|
type I pilus assembly
|
GO_0140623 |
[The assembly from its constituent parts of a type I pilus.] |
|
ER-to-endosome phospholipid transfer complex
|
GO_0140622 |
[Lipid transfer complex that is responsible for the non-vesicular transport of phospholipids, such as phosphatidylserine, from the endoplasmic reticulum to the endosome. It resides in the endosomal (acceptor) membrane and binds to specific lipids on the donor membrane at the ER-endosome contact site.] |
|
type I pilus
|
GO_0140621 |
[A short filamentous structure on the surface of a bacterial cell distinguished from other pili by their D-mannose-sensitive agglutinatination of erythrocytes. In E. coli, type I pili consist of a short tip fibrillum made up of the adhesin protein (FimH) and two minor subunits (FimG and FimF) that is joined to the pilus rod, a homopolymer of ~1000 FimA subunits.] |
|
DNA strand exchange inhibitor activity
|
GO_0140620 |
[Binds to and stops, prevents or reduces a DNA strand exchange activity.] |
|
ubiquitin-dependent protein catabolic process via the C-end degron rule pathway
|
GO_0140627 |
[The chemical reactions and pathways resulting in the breakdown of a protein or peptide covalently tagged with ubiquitin, via the DesCEND (destruction via C-end degron) pathway. In the DesCEND pathway, C-terminal residues (C-end degrons) in substrates are recognized by Cul2-RING and Cul4-RING E3 ligases, whereupon the substrates are linked to ubiquitin and then delivered to the proteasome for degradation. C-end degrons can be present in full-length proteins, truncated proteins or proteolytically cleaved forms.] |
|
opioid growth factor receptor signaling pathway
|
GO_0140626 |
[The series of molecular signals generated as a consequence of an opioid growth factor receptor binding to its physiological ligand, opioid growth factor (OGF, met-enkephalin). The OGF-OGFr complex leads to the increase in the synthesis of the selective cyclin-dependent kinase (CDK) inhibitor proteins, p12 (POLD4) and p16 (CDKN2A).] |
|
opioid growth factor receptor activity
|
GO_0140625 |
[Combining with the opioid growth factor (OGF, met-enkephalin) and transmitting the signal across the nuclear membrane. Met-enkephalin is an endogenous opioid peptide that binds to opioid and opioid growth factor receptors, regulating tissue growth in a variety of cellular processes.] |
|
EGAD pathway
|
GO_0140624 |
[The protein catabolic pathway which selectively extracts ER-resident membrane proteins exported to the Golgi and endosomes for degradation by cytosolic proteasomes. It begins with phosphorylation of the ER-resident membrane protein, which triggers export of the protein from the ER to the Golgi and endosomes, followed by polyubiquitination by the Dsc E3 ubiquitin ligase complex and extraction of the ubiquitinated target, and ends with proteasomal degradation.] |
|
DNA strand exchange activator activity
|
GO_0140619 |
[Binds to and increases a DNA strand exchange activity.] |
|
ferric-chelate reductase (NADH) activity
|
GO_0140618 |
[Catalysis of the reaction: 2 a Fe(II)-siderophore + NAD+ + H+ = 2 a Fe(III)-siderophore + NADH.] |
|
obsolete transvection
|
GO_0140617 |
[OBSOLETE. An epigenetic regulation of transcription by physical interaction between a cis-acting element (enhancer, silencer) of one allele on one chromosome and the promoter of the corresponding allele on the homologous chromosome. Transvection can lead to either gene activation or repression.] |
|
RNA sequestering activity
|
GO_0140610 |
[Binding to a specific RNA molecule to prevent it from interacting with other partners or to inhibit its localization to the area of the cell or complex where it is active.] |
|
iodotyrosine deiodinase activity
|
GO_0140616 |
[Catalyzes the reaction: 2 iodide + L-tyrosine + 2 NADP+ = 3,5-diiodo-L-tyrosine + H+ + 2 NADPH. Note that this activity has only been demonstrated in the direction of 3-deiodination. 3-bromo-L-tyrosine and 3-chloro-L-tyrosine can also be used as substrates.] |
|
ATP-dependent citrate lyase complex
|
GO_0140615 |
[A protein complex that catalyzes the cleavage of citrate into oxaloacetate and acetyl-CoA.] |
|
1,8-dihydroxynaphthalene-melanin biosynthetic process
|
GO_0140614 |
[The chemical reactions and pathways resulting in the formation of dihydroxy naphthalene (DHN)-melanin.] |
|
P-type manganese transporter activity
|
GO_0140613 |
[Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + Mn2+(in) = ADP + H+ + Mn2+(out) + phosphate.] |